Suppr超能文献

自然杀伤细胞、衰老与癌症。

Natural killer cells, ageing and cancer.

作者信息

Naumova Elissaveta, Pawelec Graham, Mihaylova Anastasiya

机构信息

Department of Clinical Immunology and Stem Cell Bank, University Hospital "Alexandrovska", Medical University, 1, Georgi Sofiiski str., 1431, Sofia, Bulgaria.

Center for Medical Research (ZMF), University of Tübingen Medical School, Tübingen, Germany.

出版信息

Cancer Immunol Immunother. 2016 Apr;65(4):367-70. doi: 10.1007/s00262-016-1817-6. Epub 2016 Mar 11.

Abstract

Natural killer (NK) cells are key components of innate immunity and substantially contribute to anti-tumor immune responses. The role of NK cells in immune surveillance is linked to many aspects of NK cell biology, but the age of the animal being studied or the human under treatment is rarely taken into account. The solicited reviews constituting a collection of papers presented here as a "Symposium-in-Writing" on the topic of NK cells, ageing and cancer were inspired by the increasing knowledge of NK cell biology and genetics, and emerging data on their impact in the clinic (disease associations and therapies), together with the realization that older individuals also differ from younger ones regarding innate as well as adaptive immunity.

摘要

自然杀伤(NK)细胞是固有免疫的关键组成部分,对抗肿瘤免疫反应有重要贡献。NK细胞在免疫监视中的作用与NK细胞生物学的许多方面相关,但所研究的动物或接受治疗的人类的年龄很少被考虑在内。这里作为关于NK细胞、衰老和癌症主题的“书面研讨会”呈现的一组论文所征集的综述,其灵感来源于对NK细胞生物学和遗传学的了解不断增加,以及它们在临床中的影响(疾病关联和治疗)方面的新出现的数据,同时也认识到老年人在固有免疫和适应性免疫方面也与年轻人不同。

相似文献

1
Natural killer cells, ageing and cancer.
Cancer Immunol Immunother. 2016 Apr;65(4):367-70. doi: 10.1007/s00262-016-1817-6. Epub 2016 Mar 11.
2
NK cell-based cancer immunotherapy: from basic biology to clinical application.
Sci China Life Sci. 2015 Dec;58(12):1233-45. doi: 10.1007/s11427-015-4970-9. Epub 2015 Nov 20.
5
Natural killer cell therapies.
Nature. 2024 Feb;626(8000):727-736. doi: 10.1038/s41586-023-06945-1. Epub 2024 Feb 21.
6
Memory-like natural killer cells for cancer immunotherapy.
Semin Hematol. 2020 Oct;57(4):185-193. doi: 10.1053/j.seminhematol.2020.11.003. Epub 2020 Nov 17.
7
Potential therapeutic role of natural killer cells in cancer.
Expert Opin Biol Ther. 2007 Jan;7(1):17-29. doi: 10.1517/14712598.7.1.17.
8
NK cell-based cancer immunotherapy: from basic biology to clinical development.
J Hematol Oncol. 2021 Jan 6;14(1):7. doi: 10.1186/s13045-020-01014-w.
9
Natural killer cells and other innate lymphoid cells in cancer.
Nat Rev Immunol. 2018 Nov;18(11):671-688. doi: 10.1038/s41577-018-0061-z.
10
[Natural killer cells: adaptation and memory in innate immunity].
Med Sci (Paris). 2013 Apr;29(4):389-95. doi: 10.1051/medsci/2013294012. Epub 2013 Apr 26.

引用本文的文献

1
Fasting and calorie restriction modulate age-associated immunosenescence and inflammaging.
Aging Med (Milton). 2024 Aug 12;7(4):499-509. doi: 10.1002/agm2.12342. eCollection 2024 Aug.
2
Counteracting Immunosenescence-Which Therapeutic Strategies Are Promising?
Biomolecules. 2023 Jul 6;13(7):1085. doi: 10.3390/biom13071085.
3
Immunosenescence, aging and successful aging.
Front Immunol. 2022 Aug 2;13:942796. doi: 10.3389/fimmu.2022.942796. eCollection 2022.
4
Advances in NK cell production.
Cell Mol Immunol. 2022 Apr;19(4):460-481. doi: 10.1038/s41423-021-00808-3. Epub 2022 Jan 5.
5
Restoration of aged hematopoietic cells by their young counterparts through instructive microvesicles release.
Aging (Albany NY). 2021 Nov 11;13(21):23981-24016. doi: 10.18632/aging.203689.
6
Aging-related genes are potential prognostic biomarkers for patients with gliomas.
Aging (Albany NY). 2021 May 4;13(9):13239-13263. doi: 10.18632/aging.203008.
7
Immunosenescence: a key player in cancer development.
J Hematol Oncol. 2020 Nov 10;13(1):151. doi: 10.1186/s13045-020-00986-z.
8
The Aryl Hydrocarbon Receptor and Tumor Immunity.
Front Immunol. 2018 Feb 13;9:286. doi: 10.3389/fimmu.2018.00286. eCollection 2018.

本文引用的文献

1
Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.
Cancer Immunol Immunother. 2016 Apr;65(4):427-40. doi: 10.1007/s00262-016-1806-9. Epub 2016 Feb 13.
2
CD57 in human natural killer cells and T-lymphocytes.
Cancer Immunol Immunother. 2016 Apr;65(4):441-52. doi: 10.1007/s00262-016-1803-z. Epub 2016 Feb 5.
3
Selection and expansion of natural killer cells for NK cell-based immunotherapy.
Cancer Immunol Immunother. 2016 Apr;65(4):477-84. doi: 10.1007/s00262-016-1792-y. Epub 2016 Jan 25.
4
NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy.
Cancer Immunol Immunother. 2016 Apr;65(4):485-92. doi: 10.1007/s00262-015-1761-x. Epub 2015 Nov 11.
5
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias.
Cancer Immunol Immunother. 2016 Apr;65(4):465-76. doi: 10.1007/s00262-015-1744-y. Epub 2015 Aug 20.
6
Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance.
Cancer Immunol Immunother. 2016 Apr;65(4):417-26. doi: 10.1007/s00262-015-1750-0. Epub 2015 Aug 19.
7
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?
Cancer Immunol Immunother. 2016 Apr;65(4):453-63. doi: 10.1007/s00262-015-1720-6. Epub 2015 Jun 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验